ArticleScientific reports2025
Multi-response optimization of defined and undefined serum-free media for enhanced proliferation of immortalized lamb muscle cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring ethical, sustainable and effective foetal bovine serum alternatives forFrontiers in toxicology · 2026Review
- Effects of low-serum adaptation on growth and protein expression in stably lactoferrin-overexpressing mammary alveolar cells.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The development of serum-free media (SFM) is critical for advancing the scalability and ethical viability of cultivated meat. To our knowledge, this study represents the first systematic, species-specific optimization of serum-free media for immortalized lamb muscle cells (ILMCs), introducing two novel formulations: LM7, a chemically defined medium comprising seven essential components for lamb muscle (LM), and LM8, a chemically undefined medium incorporating eight ingredients. Using design of experiments (DOE), response surface methodology (RSM), we systematically optimized both LM7 and LM8 to maximize ILMC proliferation, preserve cell morphology, and minimize media cost. A custom MATLAB-based image analysis pipeline enabled high-throughput viability classification from cell morphology. Several LM8 formulations achieved proliferation rates statistically comparable to 10% and even 20% fetal bovine serum (FBS). Both LM7 and LM8 sustained ILMC stemness (Pax 7 and Actin) and differentiation potential, as demonstrated by Desmin and myosin heavy chain staining. Finally, both media supported scalable culture in 3D microcarrier systems using CellBIND microcarriers, with significantly better performance observed for LM8 compared to LM7. These findings establish LM7 and LM8 as effective, serum-free platforms for cultivated lamb meat production, enabling both cost-efficiency and regulatory flexibility in cellular agriculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.